The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Current Concepts and Future Directions for the Assessment of Autoantibodies to Cellular Antigens Referred to as Anti-Nuclear Antibodies
Open accessAbstract
The detection of autoantibodies that target intracellular antigens, commonly termed anti-nuclear antibodies (ANA), is a serological hallmark in the diagnosis of systemic autoimmune rheumatic diseases (SARD). Different methods are available for detection of ANA and all bearing their own advantages and limitations. Most laboratories use the indirect immunofluorescence (IIF) assay based on HEp-2 cell substrates. Due to the subjectivity of this diagnostic platform, automated digital reading systems have been developed during the last decade. In addition, solid phase immunoassays using well characterized antigens have gained widespread adoption in high throughput laboratories due to their ease of use and open automation. Despite all the advances in the field of ANA detection and its contribution to the diagnosis of SARD, significant challenges persist. This review provides a comprehensive overview of the current status on ANA testing including automated IIF reading systems and solid phase assays and suggests an approach to interpretation of results and discusses meeting the problems of assay standardization and other persistent challenges.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Petri, M., Orbai, A., Alarcón, G. S., Gordon, C., Merrill, J. T., Fortin, P. R., Bruce, I. N., Isenberg, D., Wallace, D. J., Nived, O., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34473 · Cited by 5,322
Standardization of autoantibody testing: a paradigm for serology in rheumatic diseases
Meroni, P. L., Biggioggero, M., Pierangeli, S. S., Sheldon, J., Zegers, I., & Borghi, M. O. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.180 · Cited by 92
Self-citationBeigel, F., Schnitzler, F., Paul Laubender, R., Pfennig, S., Weidinger, M., Göke, B., Seiderer, J., Ochsenkühn, T., & Brand, S. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21362 · Cited by 84
Advances and applications of multiplexed diagnostic technologies in autoimmune diseases
Fritzler, M. (2006) · Lupus · doi:10.1191/0961203306lu2327oa · Cited by 78
Self-citationCOPPLE, S. S., MARTINS, T. B., MASTERSON, C., JOLY, E., & HILL, H. R. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1398.052 · Cited by 42 · cited 1×
“Today, several commercial ALBIA kits are available for the detection of autoantibodies to a variety of autoantigens [83, 85, 123–130].”
Background
Cited by
Damoiseaux, J., Andrade, L. E. C., Carballo, O. G., Conrad, K., Francescantonio, P. L. C., Fritzler, M. J., Garcia de la Torre, I., Herold, M., Klotz, W., Cruvinel, W. D. M., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214436 · Cited by 378
Self-citationChemiluminescent immunoassay technology: what does it change in autoantibody detection?
Cinquanta, L., Fontana, D. E., & Bizzaro, N. (2017) · Autoimmunity Highlights · doi:10.1007/s13317-017-0097-2 · Cited by 287
Toward new criteria for systemic lupus erythematosus-a standpoint
Aringer, M., Dörner, T., Leuchten, N., & Johnson, S. R. (2016) · Lupus · doi:10.1177/0961203316644338 · Cited by 93
Mummert, E., Fritzler, M. J., Sjöwall, C., Bentow, C., & Mahler, M. (2018) · Journal of Immunological Methods · doi:10.1016/j.jim.2018.05.014 · Cited by 86
Self-citationDetection of autoantibodies using chemiluminescence technologies
Mahler, M., Bentow, C., Serra, J., & Fritzler, M. J. (2016) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2015.1077461 · Cited by 47
Metadata
- Authors
- Mahler, M., Meroni, P.-L., Bossuyt, X., & Fritzler, M. J.
- Venue
- Journal of Immunology Research
- Publisher
- Hindawi Limited
- Published
- 2014
- Volume
- 2014
- Pages
- 1-18
- ISSN
- 2314-7156 (ISSN-L)
- 2314-8861
- OpenAlex
- W1999506970
- Cited by
- 203
- References
- 5
- FWCI
- 14.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.